A hypersensitivity reaction – termed the 'sulfone syndrome' or 'dapsone syndrome' – may infrequently develop during the first six weeks of treatment. This syndrome consists of exfoliative dermatitis, fever, malaise, nausea, anorexia, hepatitis, jaundice, lymphadenopathy and hemolytic anemia.